The result is a compound with a highly targeted metabolic research profile. AOD-9604 stimulates lipolysis through beta-3 adrenergic receptor engagement and mimics the fat-metabolizing activity of native growth hormone without binding to the GH receptor or activating IGF-1 production pathways. This receptor selectivity makes it an exceptionally precise research tool for investigating adipose tissue metabolism in isolation from the broader anabolic and mitogenic effects that complicate interpretation when using full-length growth hormone in metabolic studies.

Beyond its primary lipolytic mechanism, emerging research has explored AOD-9604’s potential relevance in cartilage and bone repair pathways, suggesting biological activity that extends beyond adipose tissue, a finding that has broadened its appeal across metabolic, orthopedic, and regenerative biology research disciplines. Its well-characterized safety profile in preclinical and early clinical studies further supports its utility as a reliable long-term research compound.

Research applications include adipose tissue lipolysis and lipogenesis regulation studies, beta-3 adrenergic receptor signaling investigations, obesity-related metabolic dysfunction modeling, comparative fat metabolism research against full-length growth hormone, cartilage repair and chondrocyte activity studies, and body composition mechanism research in metabolic disease models.

All vials are independently HPLC-validated and mass-spectrometry confirmed for sequence fidelity and 99%+ purity, with complete third-party COA documentation available.

Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight: 1,817.07 g/mol
Storage: Lyophilized at −20°C | Reconstitute under sterile conditions

FOR RESEARCH USE ONLY